AKT phosphorylates targets in the cytosol |
Pathways_-_Reactome.gmt.txt |
-2.4 |
0.03496 |
10.0 |
4.0 |
1.22 |
ALDO KETO REDUCTASE ACTIVITY |
GO_-_Molecular_Function.gmt.txt |
-3.0 |
0.03452 |
5.0 |
3.0 |
0.61 |
BIOCARTA ARAP PATHWAY |
Pathways_-_KEGGBioCarta.gmt.txt |
-3.0 |
0.02854 |
8.0 |
4.0 |
0.98 |
BIOCARTA FEEDER PATHWAY |
Pathways_-_KEGGBioCarta.gmt.txt |
-3.0 |
0.02854 |
5.0 |
3.0 |
0.61 |
BIOCARTA PTDINS PATHWAY |
Pathways_-_KEGGBioCarta.gmt.txt |
-2.8 |
0.03296 |
12.0 |
5.0 |
1.47 |
BIOCARTA RARRXR PATHWAY |
Pathways_-_KEGGBioCarta.gmt.txt |
-3.0 |
0.02854 |
8.0 |
4.0 |
0.98 |
BIOCARTA VDR PATHWAY |
Pathways_-_KEGGBioCarta.gmt.txt |
-3.0 |
0.02854 |
5.0 |
3.0 |
0.61 |
CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY |
GO_-_Molecular_Function.gmt.txt |
-3.0 |
0.03452 |
5.0 |
3.0 |
0.61 |
Cell-extracellular matrix interactions |
Pathways_-_Reactome.gmt.txt |
-2.2 |
0.04191 |
7.0 |
3.0 |
0.86 |
EGFR downregulation |
Pathways_-_Reactome.gmt.txt |
-2.3 |
0.04098 |
19.0 |
6.0 |
2.33 |
EXTRACELLULAR REGION |
GO_-_Cellular_Component.gmt.txt |
-2.6 |
0.04052 |
62.0 |
15.0 |
7.59 |
EXTRACELLULAR SPACE |
GO_-_Cellular_Component.gmt.txt |
-2.5 |
0.04332 |
31.0 |
9.0 |
3.79 |
Energy dependent regulation of mTOR by LKB1-AMPK |
Pathways_-_Reactome.gmt.txt |
-2.2 |
0.04598 |
11.0 |
4.0 |
1.35 |
GGGGCCC,MIR-296 |
TFmiRNA_Targets.gmt.txt |
-3.9 |
0.03237 |
26.0 |
10.0 |
3.18 |
HIV Nef Mediated CD8 Down-regulation |
HIV_Collection.gmt.txt |
-3.0 |
0.0246 |
5.0 |
3.0 |
0.61 |
HIV human PPI VIF |
HIV_Collection.gmt.txt |
-3.0 |
0.0246 |
19.0 |
7.0 |
2.33 |
KEGG ENDOCYTOSIS |
Pathways_-_KEGGBioCarta.gmt.txt |
-3.6 |
0.01614 |
88.0 |
22.0 |
10.77 |
KEGG GALACTOSE METABOLISM |
Pathways_-_KEGGBioCarta.gmt.txt |
-2.4 |
0.0481 |
14.0 |
5.0 |
1.71 |
KEGG HYPERTROPHIC CARDIOMYOPATHY HCM |
Pathways_-_KEGGBioCarta.gmt.txt |
-2.4 |
0.04745 |
18.0 |
6.0 |
2.2 |
Nuclear Receptor transcription pathway |
Pathways_-_Reactome.gmt.txt |
-2.6 |
0.02439 |
9.0 |
4.0 |
1.1 |
Phase 1 - Functionalization of compounds |
Pathways_-_Reactome.gmt.txt |
-3.0 |
0.01492 |
5.0 |
3.0 |
0.61 |
Potassium Channels |
Pathways_-_Reactome.gmt.txt |
-2.2 |
0.04394 |
15.0 |
5.0 |
1.84 |
Regulation of Rheb GTPase activity by AMPK |
Pathways_-_Reactome.gmt.txt |
-3.0 |
0.01492 |
5.0 |
3.0 |
0.61 |
Trafficking of AMPA receptors |
Pathways_-_Reactome.gmt.txt |
-2.8 |
0.01969 |
12.0 |
5.0 |
1.47 |
Trafficking of GluR2-containing AMPA receptors |
Pathways_-_Reactome.gmt.txt |
-2.6 |
0.02439 |
9.0 |
4.0 |
1.1 |
V$PPAR DR1 Q2 |
TFmiRNA_Targets.gmt.txt |
-3.5 |
0.04626 |
83.0 |
21.0 |
10.16 |
Voltage gated Potassium channels |
Pathways_-_Reactome.gmt.txt |
-2.6 |
0.02804 |
6.0 |
3.0 |
0.73 |
chr11q13 |
Chromosomal_Bands.gmt.txt |
-2.1 |
0.0424 |
94.0 |
19.0 |
11.5 |
chr15q23 |
Chromosomal_Bands.gmt.txt |
-2.0 |
0.04729 |
8.0 |
3.0 |
0.98 |
chr16p13 |
Chromosomal_Bands.gmt.txt |
-3.0 |
0.01679 |
102.0 |
23.0 |
12.48 |
chr17p13 |
Chromosomal_Bands.gmt.txt |
-5.7 |
2.1E-4 |
81.0 |
25.0 |
9.91 |
chr17q25 |
Chromosomal_Bands.gmt.txt |
-5.2 |
3.9E-4 |
66.0 |
21.0 |
8.08 |
chr19p13 |
Chromosomal_Bands.gmt.txt |
-8.4 |
0.0 |
191.0 |
52.0 |
23.38 |
chr19q13 |
Chromosomal_Bands.gmt.txt |
-5.9 |
2.1E-4 |
208.0 |
49.0 |
25.46 |
chr22q13 |
Chromosomal_Bands.gmt.txt |
-3.0 |
0.01679 |
68.0 |
17.0 |
8.32 |
chr2q35 |
Chromosomal_Bands.gmt.txt |
-2.4 |
0.028 |
14.0 |
5.0 |
1.71 |
chr8q24 |
Chromosomal_Bands.gmt.txt |
-2.6 |
0.02396 |
51.0 |
13.0 |
6.24 |
chr9p13 |
Chromosomal_Bands.gmt.txt |
-2.8 |
0.01992 |
16.0 |
6.0 |
1.96 |
chr9q34 |
Chromosomal_Bands.gmt.txt |
-2.5 |
0.02637 |
86.0 |
19.0 |
10.53 |